2461 studies found for:    "Hepatitis A"
Show Display Options
Rank Status Study
21 Not yet recruiting Study to Assess Seroprevalence of Hepatitis A, Hepatitis B and Bordetella Pertussis in Mexico
Condition: Hepatitis A
Intervention: Other: Data collection
22 Completed
Has Results
A Study to Evaluate the Safety and Immunogenicity of the Hepatitis A Virus Vaccine HAVpur in Healthy Young Children
Condition: Hepatitis A
Interventions: Biological: HAVpur Junior;   Biological: Havrix 720 Junior
23 Not yet recruiting Evaluation of the Long-term Persistence of Hepatitis A Antibodies in Healthy Adults Who Were Vaccinated 21-25 Years Earlier With GlaxoSmithKline (GSK) Biologicals' Hepatitis A Vaccine, Havrix®
Condition: Hepatitis A
Intervention: Procedure: Blood sampling
24 Completed
Has Results
Long-Term Immune Persistence of GlaxoSmithKline Biologicals' Inactivated Hepatitis A Vaccine, Injected According to 0, 6-month Schedule
Condition: Hepatitis A
Intervention: Biological: Havrix™
25 Completed
Has Results
Long-Term Immune Persistence of GlaxoSmithKline Biologicals' Inactivated Hepatitis A Vaccine Injected According to a 0, 12-month Schedule
Condition: Hepatitis A
Intervention: Biological: Havrix™
26 Completed Hepatitis A Vaccine in Patients With Immunomodulating Drugs
Condition: Response to Hepatitis A Vaccine
Intervention: Biological: hepatitis A vaccine ( HAVRIX or EPAXAL)
27 Completed Long Term Follow-up of a Study to Assess the Safety and Immunogenicity of a Hepatitis A Vaccine Administered With and in the Absence of DTPaHibIPV, OPV and MMR Vaccines
Condition: Hepatitis A
Interventions: Biological: Epaxal;   Biological: Havrix 720
28 Completed Surveillance Study to Determine the Trends in Acute Hepatitis A Among Panamanian Children
Conditions: Acute Hepatitis A;   Hepatitis
Intervention: Procedure: Serum sample
29 Completed
Has Results
Concomitant Use of Hepatitis A Vaccine With Measles, Mumps, Rubella and Varicella Vaccine and Pneumococcal 7-Valent Conjugate Vaccine in Healthy 12-Month-Old Children (V251-067)(COMPLETED)
Condition: Hepatitis A Virus
Interventions: Biological: Comparator: VAQTA™ (Hepatitis A vaccine);   Biological: Comparator: ProQuad™ (Measles, Mumps, Rubella and Varicella vaccine);   Biological: Comparator: Prevnar™ (Pneumococcal 7-Valent Conjugate vaccine)
30 Completed
Has Results
Concomitant Use of Hepatitis A Vaccine, Inactivated With Haemophilus b Conjugate Vaccine (Meningococcal Protein Conjugate) and Diphtheria and Tetanus Toxoids and Acellular Pertussis Vaccine Adsorbed Given to Healthy Children 15 Months of Age (V251-068)
Condition: Hepatitis A Virus
Interventions: Biological: Comparator: VAQTA™;   Biological: Comparator: Infanrix™;   Biological: Comparator: PedvaxHIB™
31 Not yet recruiting PCV13 + Hepatitis A Vaccine for Adults
Conditions: Measurement of Immune Response to Prevenar13;   Measurement of Immune Response to Hepatitis A
Interventions: Biological: Prevenar13;   Biological: Hepatitis A vaccine
32 Completed
Has Results
Immunogenicity and Safety of Havrix™ Co-Administered With a Diphtheria, Tetanus and Pertussis and a Haemophilus b Vaccine in Children Aged 15 Months
Conditions: Hepatitis A Vaccine;   Hepatitis A
Interventions: Biological: Havrix™;   Biological: Infanrix™;   Biological: ActHIB™
33 Completed
Has Results
Long-Term Follow-Up Studies at Year 6, 7, 8, 9, 10: 2 Formulations of Combined Hepatitis A/B Vaccine Compared in Subjects Aged 12-15 Years
Conditions: Hepatitis B;   Hepatitis A
Interventions: Biological: Twinrix™ Adult;   Biological: Twinrix™ Junior
34 Completed
Has Results
Long Term Follow-up Study at Years 2, 3, 4 and 5 Where 2 Dosing Schedules of the Combined Hepatitis A and B Vaccine Were Compared
Conditions: Hepatitis B;   Hepatitis A
Interventions: Biological: Twinrix™ Adult;   Biological: Twinrix™ Junior
35 Completed Safety and Immunogenicity Study of an Inactivated Hepatitis A Vaccine
Condition: Hepatitis A
Interventions: Biological: inactivated hepatitis A vaccine Healive®;   Biological: inactivated hepatitis A vaccine
36 Completed Immunogenicity and Interchangeability of Two Inactivated Hepatitis A Vaccines
Condition: Hepatitis A
Interventions: Biological: Healive+Healive;   Biological: Healive+Havrix;   Biological: Havrix+Havrix;   Biological: Havrix+Healive
37 Completed Comparative Study in Healthy Adults Aged 18-50 Yrs Administered With Hepatyrix or Havrix+Typherix or Tiphim Vi, to Compare Reactogenicity & Immunogenicity
Conditions: Hepatitis B;   Typhoid;   Hepatitis A
Intervention: Biological: Combined Vi polysaccharide typhoid vaccine and hepatitis A vaccine- Hepatyrix
38 Completed Safety of GlaxoSmithKline (GSK) Biologicals Hepatitis A Vaccine in Korean Population
Condition: Hepatitis A
Intervention: Biological: Hepatitis A
39 Completed Comparison of Immunogenicity and Safety of Inactivated and Live Attenuated Hepatitis A Vaccines in Young Adults
Condition: Hepatitis A
Interventions: Biological: Inactivated HAV vaccine;   Biological: Live attenuated HAV vaccine
40 Completed Immune Response & Safety of a Hepatitis A Vaccine Given Together With a Pneumococcal Vaccine in Healthy Children 15 m of Age
Condition: Hepatitis A
Intervention: Biological: Hepatitis A

Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results
Indicates status has not been verified in more than two years